← Back to Clinical Trials
Recruiting NCT07138963

NCT07138963 Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07138963
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Phenotype
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2024-06-30
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
Genetic Testing and Muscle Biopsy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 25 participants in total. It began in 2024-06-30 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to correlate the phenotype and genotype among a sample of Egyptian patients with Congenital myopathies and Congenital muscular dystrophies.

Eligibility Criteria

Inclusion Criteria: * Patients with clinical criteria of Congenital Myopathies (CMs) and Congenital Muscular dystrophies (CMDs) with different modes of inheritance. * Age: patients below age of 18 years. * Gender: Both males and females are included * Genetically confirmed CMs and CMDs. Exclusion Criteria: * Patients above 18 years. * Spinal muscular atrophy (SMA),and root lesions. * Congenital myasthenic syndromes * Dystrophinopathies,Duchenne Muscular Dystrophy (DMD), Limb-Girdle Muscular Dystrophy (LGMD) * .Metabolic myopathies * .Inflammatory muscle diseases

Contact & Investigator

Central Contact

Nouran M Sabry, MSc

✉ nouran.abdelaziz@med.asu.edu.eg

📞 00201092289982

Frequently Asked Questions

Who can join the NCT07138963 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Phenotype. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07138963 currently recruiting?

Yes, NCT07138963 is actively recruiting participants. Contact the research team at nouran.abdelaziz@med.asu.edu.eg for enrollment information.

Where is the NCT07138963 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07138963 clinical trial?

NCT07138963 is sponsored by Ain Shams University. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology